Goutham Vemana, MD, explained how the intravesical system provides continuous treatment exposure, deeper bladder penetration, and zero systemic absorption.
Goutham Vemana, MD
Advertisement
Articles by Goutham Vemana, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
3
What Does an End-of-Life Doula Do for Patients With Cancer?
4
GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology
5